Medglobe Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.75 Cr
as on 24-10-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.10 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.50 Cr
as on 24-10-2024
- Revenue 72.79%
(FY 2023)
- Profit 24.58%
(FY 2023)
- Ebitda 42.85%
(FY 2023)
- Net Worth 68.15%
(FY 2023)
- Total Assets 33.28%
(FY 2023)
About Medglobe Therapeutics
The Corporate was formerly known as Opus Life Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.75 Cr.
The company currently has active open charges totaling ₹4.10 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Singh, Varun Singh, and Anuj Garawal serve as directors at the Company.
- CIN/LLPIN
U24239DL2006PLC368703
- Company No.
050002
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medglobe Therapeutics Limited offer?
Medglobe Therapeutics Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Medglobe Therapeutics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Singh  | Director | 03-Jan-2019 | Current |
| Varun Singh | Director | 05-Mar-2019 | Current |
| Anuj Garawal | Director | 03-Jan-2019 | Current |
Financial Performance of Medglobe Therapeutics.
Medglobe Therapeutics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.79% increase. The company also saw a substantial improvement in profitability, with a 24.58% increase in profit. The company's net worth Soared by an impressive increase of 68.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medglobe Therapeutics?
In 2023, Medglobe Therapeutics had a promoter holding of 63.01% and a public holding of 36.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jun 2024 | ₹4.10 Cr | Open |
Punjab National Bank Creation Date: 01 Sep 2006 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Medglobe Therapeutics?
Medglobe Therapeutics has a workforce of 57 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medglobe Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medglobe Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
